Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145751 | SCV000192877 | likely benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000724245 | SCV000228235 | uncertain significance | not provided | 2014-11-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002055881 | SCV002335249 | likely benign | Rubinstein-Taybi syndrome | 2024-12-18 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000724245 | SCV001932803 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000724245 | SCV001972835 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003935242 | SCV004748127 | likely benign | CREBBP-related disorder | 2021-06-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |